Jeffrey L. Edelman

1.3k total citations
18 papers, 1.0k citations indexed

About

Jeffrey L. Edelman is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jeffrey L. Edelman has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 8 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jeffrey L. Edelman's work include Retinal Diseases and Treatments (11 papers), Glaucoma and retinal disorders (6 papers) and Retinal Development and Disorders (3 papers). Jeffrey L. Edelman is often cited by papers focused on Retinal Diseases and Treatments (11 papers), Glaucoma and retinal disorders (6 papers) and Retinal Development and Disorders (3 papers). Jeffrey L. Edelman collaborates with scholars based in United States, Ireland and Canada. Jeffrey L. Edelman's co-authors include David J. Lutz, A Nehmé, Shalesh Kaushal, Matthew A. Cunningham, W. Daniel Stamer, Edward K. Lobenhofer, George Sachs, Tao Kang, Yi Wen and Allen Dearry and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Jeffrey L. Edelman

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Jeffrey L. Edelman

Since Specialization

Citations

This map shows the geographic impact of Jeffrey L. Edelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Edelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Edelman more than expected).

Fields of papers citing papers by Jeffrey L. Edelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Edelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Edelman. The network helps show where Jeffrey L. Edelman may publish in the future.

Co-authorship network of co-authors of Jeffrey L. Edelman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey L. Edelman. A scholar is included among the top collaborators of Jeffrey L. Edelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey L. Edelman. Jeffrey L. Edelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery 2021 ·Nature Communications ·Kyle G. Battiston, (unknown), (unknown), (unknown), Hans Fischer, (unknown), (unknown), Fan Gu, (unknown), Bingqing Yang, (unknown), (unknown), Heather Sheardown, Leonid Kalachev, Christopher Crean, Jeffrey L. Edelman, J. Paul Santerre, (unknown)	32
2	Ocular pharmacokinetics, pharmacodynamics, and safety analysis of a novel dexamethasone intravitreal implant 2020 ·Investigative Ophthalmology & Visual Science ·(unknown), (unknown), Hans Fischer, (unknown), (unknown), Kyle G. Battiston, (unknown), (unknown), (unknown), Heather Sheardown, Jeffrey L. Edelman, Christopher Crean, (unknown)	1
3	Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells 2015 ·Drug Design Development and Therapy ·(unknown), (unknown), (unknown), Chunfang Ha, Xueyu Zhang, (unknown), (unknown), Jeffrey L. Edelman, Dong Wang, (unknown), Xueji Zhang, (unknown), (unknown), (unknown)	63
4	Involvement of tristetraprolin in transcriptional activation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin 2012 ·Biochemical and Biophysical Research Communications ·Gene C. Ness, Jeffrey L. Edelman, Patricia A. Brooks	4
5	Retinal Gene Expression and Visually Evoked Behavior in Diabetic Long Evans Rats 2011 ·Investigative Ophthalmology & Visual Science ·(unknown), (unknown), (unknown), Belinda Cairns, (unknown), Jeffrey L. Edelman	35
6	Differentiating Intraocular Glucocorticoids 2010 ·Ophthalmologica ·Jeffrey L. Edelman	67
7	Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells 2009 ·BMC Medical Genomics ·A Nehmé, Edward K. Lobenhofer, W. Daniel Stamer, Jeffrey L. Edelman	82
8	Strain-Dependent Increases in Retinal Inflammatory Proteins and Photoreceptor FGF-2 Expression in Streptozotocin-Induced Diabetic Rats 2009 ·Investigative Ophthalmology & Visual Science ·(unknown), (unknown), (unknown), Jeffrey L. Edelman	28
9	Dexamethasone Inhibits High Glucose–, TNF-α–, and IL-1β–Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes 2008 ·Investigative Ophthalmology & Visual Science ·A Nehmé, Jeffrey L. Edelman	71
10	Intravitreal Steroids for Macular Edema: The Past, the Present, and the Future 2008 ·Survey of Ophthalmology ·Matthew A. Cunningham, Jeffrey L. Edelman, Shalesh Kaushal	107
11	A functional radioreceptor assay of alpha-V-beta-3 (αvβ3) inhibitors in plasma: Application as an ex vivo pharmacodynamic model 2005 ·Journal of Biochemical and Biophysical Methods ·Margery A. Chaikin, Juan Marugán, Gerald W. De Vries, Peter Baciu, Jeffrey L. Edelman, Ming Ni, Bruce E. Tomczuk, Wenxi Pan, (unknown), (unknown), Kristi Leonard, Stephen Eisennagel, Christopher J. Molloy, Carl L. Manthey	1
12	Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood–retinal and blood–aqueous barrier breakdown 2004 ·Experimental Eye Research ·Jeffrey L. Edelman, David J. Lutz, (unknown)	196
13	Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization 2004 ·Experimental Eye Research ·(unknown), David J. Lutz, Jeffrey L. Edelman	49
14	Quantitative Image Analysis of Laser-induced Choroidal Neovascularization in Rat 2000 ·Experimental Eye Research ·Jeffrey L. Edelman, (unknown)	129
15	Lipocortin V May Function as a Signaling Protein for Vascular Endothelial Growth Factor Receptor-2/Flk-1 1999 ·Biochemical and Biophysical Research Communications ·Yi Wen, Jeffrey L. Edelman, Tao Kang, George Sachs	18
16	Two Functional Forms of Vascular Endothelial Growth Factor Receptor-2/Flk-1 mRNA Are Expressed in Normal Rat Retina 1998 ·Journal of Biological Chemistry ·Yi Wen, Jeffrey L. Edelman, Tao Kang, Ningxin Zeng, George Sachs	51
17	Dopamine Induces Light‐Adaptive Retinomotor Movements in Bullfrog Cones via D2 Receptors and in Retinal Pigment Epithelium via D1 Receptors 1990 ·Journal of Neurochemistry ·Allen Dearry, Jeffrey L. Edelman, Sheldon S. Miller, Beth Burnside	55
18	The Formation of Oligosaccharides by Enzymic Transglycosylation 1956 ·Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects ·Jeffrey L. Edelman	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact